Sergio Cantoreggi
Group Chief Scientific Officer, Global Head of R&D
Biography
- +20 yrs of experience in the pharmaceutical business
- Joined Helsinn Healthcare in 2000 as drug development scientist and was appointed Head of R&D in 2005
- Prior to Helsinn, he worked as toxicologist and regulatory scientist for Sandoz and Novartis
- MS in Chemistry and PhD in Natural Sciences at ETH in Zürich, followed by two post-doctoral fellowships in Switzerland and in the U.S.
Helsinn’s Senior Executive Committee Team
Riccardo Braglia
Executive Chairman
Konrad Wilson
Group Chief Financial Officer
Dr. Melanie Rolli
Group Chief Executive Officer
Giorgio Calderari
Vice Chairman
Matteo Missaglia
Group General Counsel, Group Chief Legal Officer
Sergio Cantoreggi
Group Chief Scientific Officer, Global Head of R&D
Georg Büchner
Group Chief Business Officer
Roberta Cannella
Group Chief Manufacturing Officer